𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumeur stromales non résécables traitées par Imatinib : doit-on faire l’ablation des lésions résiduelles ?: C. Scaife, K. Hunt, S. Patel, R. Benjamin, M. Burgess, L. Chen, J. Trent, K. Raymond, J. Cormier, P. Pister, R. Pollock, B. Feig Is there a role for surgery in patients with “unresectable” c KIT + gastrointestinal stromal tumors treated with imatinib mesylate? Am J Surg 2003;186:665-669

✍ Scribed by B. Dousset; Ph. de Mestier; C. Vons


Book ID
114045151
Publisher
Masson Editeur
Year
2004
Tongue
French
Weight
57 KB
Volume
141
Category
Article
ISSN
0021-7697

No coin nor oath required. For personal study only.